Expertise in
13
conditions

Dr. Brian K. Ulrich

Oncology
Texas Oncology Pharmacy-Wichita Falls
5400 Kell Blvd, 
Wichita Falls, TX 
Accepting New Patients
Offers Telehealth
Expertise in
13
conditions
Texas Oncology Pharmacy-Wichita Falls
5400 Kell Blvd, 
Wichita Falls, TX 

Overview

Brian Ulrich is an Oncologist practicing medicine in Wichita Falls, Texas.

Dr. Ulrich is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Familial Colorectal Cancer, Pleuropulmonary Blastoma, and Myelodysplastic Syndrome (MDS).

He is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 7 clinical trials. Dr. Ulrich is currently accepting new patients.

Specialties

Oncology

Licenses

Internal Medicine in TX

Hospital Affiliations

Graham Regional Medical Center
United Regional Health Care System

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EMI Health
  • PPO
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Texas Oncology Pharmacy-Wichita Falls
5400 Kell Blvd, Wichita Falls, TX 76310
Other Locations
Steven Kent Jones MD PA
1339 East St, Graham, TX 76450

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

The Circulating Cell-free Genome Atlas Study
The Circulating Cell-free Genome Atlas Study
Enrollment Status: Unknown
Publish Date: September 13, 2023
A Randomized Phase 2 Trial of AM0010 in Combination With Pembrolizumab vs. Pembrolizumab Alone as First-Line (1L) Therapy in Patients With Stage IV / Metastatic Wild Type (WT) Non-Small Cell Lung Cancer and Tumors With High Expression of PD-L1 (> 50%)
A Randomized Phase 2 Trial of AM0010 in Combination With Pembrolizumab vs. Pembrolizumab Alone as First-Line (1L) Therapy in Patients With Stage IV / Metastatic Wild Type (WT) Non-Small Cell Lung Cancer and Tumors With High Expression of PD-L1 (> 50%)
Enrollment Status: Terminated
Publish Date: January 20, 2021
Intervention Type: Drug, Biological
Study Phase: Phase 2
Randomized Study of AM0010 in Combination With FOLFOX Compared to FOLFOX Alone as Second-line Tx in Pts With Metastatic Pancreatic Cancer That Has Progressed During or Following a First-Line Gemcitabine Containing Regimen
Randomized Study of AM0010 in Combination With FOLFOX Compared to FOLFOX Alone as Second-line Tx in Pts With Metastatic Pancreatic Cancer That Has Progressed During or Following a First-Line Gemcitabine Containing Regimen
Enrollment Status: Completed
Publish Date: October 19, 2020
Intervention Type: Biological, Drug
Study Phase: Phase 3
A Randomized Phase 2 Trial of AM0010 in Combination With Nivolumab vs. Nivolumab Alone as Second-Line Therapy in Subjects With Stage IV / Metastatic Wild Type Non-Small Cell Lung Cancer and Low Tumor Expression of PD-L1
A Randomized Phase 2 Trial of AM0010 in Combination With Nivolumab vs. Nivolumab Alone as Second-Line Therapy in Subjects With Stage IV / Metastatic Wild Type Non-Small Cell Lung Cancer and Low Tumor Expression of PD-L1
Enrollment Status: Terminated
Publish Date: September 11, 2020
Intervention Type: Biological, Drug
Study Phase: Phase 2
A Single-Arm, Global, Phase 4 Study of Abemaciclib, a CDK 4 & 6 Inhibitor, in Combination With Nonsteroidal Aromatase Inhibitors (Anastrozole or Letrozole) in Participants With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative Advanced Breast Cancer With Poor Prognostic Factors
A Single-Arm, Global, Phase 4 Study of Abemaciclib, a CDK 4 & 6 Inhibitor, in Combination With Nonsteroidal Aromatase Inhibitors (Anastrozole or Letrozole) in Participants With Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative Advanced Breast Cancer With Poor Prognostic Factors
Enrollment Status: Withdrawn
Publish Date: September 06, 2019
Intervention Type: Drug
Study Phase: Phase 4
View 4 Less Clinical Trials

2 Total Publications

PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung Cancer.
PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung Cancer.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: February 12, 2016
Similar Doctors
Expertise in
34
conditions
Expertise in
34
conditions
Referral may be required

Texas Oncology Pharmacy-Wichita Falls

5400 Kell Blvd, 
Wichita Falls, TX 
 (0.1 miles away)
940-691-8271
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jagathi Challagalla is an Oncologist practicing medicine in Wichita Falls, Texas. Dr. Challagalla is highly rated in 34 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Inflammatory Breast Cancer, Familial Colorectal Cancer, and Breast Cancer. Dr. Challagalla is currently accepting new patients.

Expertise in
31
conditions
Expertise in
31
conditions
Referral may be required
Before you request

Texas Oncology Pharmacy-Wichita Falls

5400 Kell Blvd, 
Wichita Falls, TX 
 (0.1 miles away)
940-691-8271
Languages Spoken:
English, Hindi, Punjabi, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Manmeet Mangat is an Oncologist practicing medicine in Wichita Falls, Texas. Dr. Mangat is highly rated in 31 conditions, according to our data. His clinical expertise encompasses Familial Colorectal Cancer, Paget Disease of the Breast, Lynch Syndrome, Colorectal Cancer, and Bone Marrow Aspiration. Dr. Mangat is currently accepting new patients.

Expertise in
16
conditions
Expertise in
16
conditions
Referral may be required

Cancer Centers Of Southwest Oklahoma LLC

104 NW 31st St, 
Lawton, OK 
 (51.7 miles away)
580-536-2121
Languages Spoken:
English, Mandarin
See accepted insurances
Accepting New Patients
Offers Telehealth

Yixing Jiang is an Oncologist practicing medicine in Lawton, Oklahoma. Dr. Jiang is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Anal Cancer, and Gastrostomy. Dr. Jiang is currently accepting new patients.

Frequently Asked Questions about Dr. Brian K. Ulrich

How do I make an appointment with Dr. Brian K. Ulrich?

You can book an appointment with Dr. Brian K. Ulrich by calling their office at 940-691-8271. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Brian K. Ulrich a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Brian K. Ulrich is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Brian K. Ulrich specialize in?

While Dr. Brian K. Ulrich is a Oncology, they have specific expertise in Lung Cancer, Familial Colorectal Cancer, and Pleuropulmonary Blastoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.

Does Dr. Brian K. Ulrich participate in research or clinical trials?

Yes. Dr. Brian K. Ulrich has published 2 articles and abstracts on conditions like Lung Cancer. You can view a list of Dr. Brian K. Ulrich's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Brian K. Ulrich accept my insurance?

Dr. Brian K. Ulrich accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 940-691-8271 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ulrich's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 67 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile